Immune effect of hypertonic saline: Fact or fiction?

Acta Anaesthesiologica Scandinavica

Volumn 48, Issue 6, 2004, Pages 667-678

  Kølsen Petersen, Jens Aage ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

Cytokines; Hypertonic, killer cells, lymphocyte; Macrophages; Natural; Neutrovhils; Saline solution

Indexed keywords

BETA INTERFERON; BETA2 INTEGRIN; CHLORIDE ION; ELASTASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GAMMA INTERFERON; HYPERTONIC SOLUTION; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; PADGEM PROTEIN; PLASMA SUBSTITUTE; SODIUM CHLORIDE; SODIUM ION; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

CYTOKINE PRODUCTION; DEGRANULATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFUSION; INJURY; MAJOR SURGERY; MORBIDITY; MORTALITY; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PLASMA OSMOLALITY; PLASMA OSMOLARITY; PLASMA VOLUME; PRIORITY JOURNAL; REPERFUSION; RESPIRATORY BURST; RESUSCITATION; REVIEW; SHOCK; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; BIOLOGICAL MARKERS; CYTOKINES; HUMANS; IMMUNITY; LEUKOCYTES; MICE; OSMOLAR CONCENTRATION; RATS; SALINE SOLUTION, HYPERTONIC;

EID: 3042533388     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2004.00396.x     Document Type: Review

References (106)

1. Kramer GC. Hypertonic resuscitation. physiologic mechanisms and recommendations for trauma care. J Trauma 2003; 54: S89-S99.
2. Brauer LP, Svensen CH, Hahn RG, Kilicturgay S, Kramer GC, Prough DS. Influence of rate and volume of infusion on the kinetics of 0.9% saline and 7.5% saline/6.0% dextran 70 in sheep. Anesth Analg 2002; 95: 1547-56.
3. Tollofsrud S, Elgjo GI, Prough DS, Williams CA, Traber DL, Kramer GC. The dynamics of vascular Volume and fluid shifts of lactated Ringer's solution and hypertonic-saline-dextran solutions infused in normovolemic sheep. Anesth Analg 2001; 93: 823-31.
4. Mazzoni MC, Borgstrom P, Intaglietta M, Arfors KE. Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 1990; 31: 407-18.
5. Kreimeier U, Brueckner UB, Schmidt J, Messmer K. Instantaneous restoration of regional organ blood flow after severe hemorrhage: effect of small-Volume resuscitation with hypertonic-hyperoncotic solutions. J Surg Res 1990; 49: 493-503.
6. Ciesla DJ, Moore EE, Zallen G, Biffl WL, Silliman CC. Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: timing is everything. J Trauma 2000; 48: 388-95.
7. Pascual JL, Ferri LE, Seely AJ et al. Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage. Ann Surg 2002; 236: 634-42.
8. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol 1998; 161: 6288-96.
9. Rosengren S, Henson PM, Worthen GS. Migration-associated Volume changes in neutrophils facilitate the migratory process in vitro. Am J Physiol 1994; 267: C1623-32.
10. Junger WG, Coimbra R, Liu FC et al. Hypertonic saline resusCitation. a tool to modulate immune function in trauma patients? Shock 1997; 8: 235-41.
11. Loomis WH, Namiki S, Ostrom RS, Insel PA, Junger WG. Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J Biol Chem 2003; 278: 4590-6.
12. Loomis WH, Namiki S, Hoyt DB, Junger WG. Hypertonicity rescues TceUs from suppression by trauma-induced anti-inflammatory mediators. Am J Physiol Cell Physiol 2001; 281: C840-8.
13. Partrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz 1996; 4: 194-210.
14. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
15. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996; 20: 454-9.
16. Angle N, Cabello-Passini R, Hoyt DB et al. Hypertonic saline infusion: can it regulate human neutrophil function? Shock 2000; 14: 503-8.
17. Kølsen-Petersen JA, Nielsen JOD, Tonnesen E. Effect of Hypertonic Saline Infusion on Postoperative Immune Function. A Randomized Controlled Clinical Trial. Anesthesiology, in press.
18. Kølsen-Petersen JA, Nielsen JOD, Bendtzen K, Tonnesen E. Infusion of hypertonic saline (7.5%) causes minor immunological changes in normovolemic women. Acta Anaesthesiol Scand 2004; 48: 224-33.
19. Rizoli SB, Rotstein OD, Kapus A. Cell volume -dependent regulation of 1-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. J Biol Chem 1999; 274: 22072-80.
20. Junger WG, Liu FC, Loomis WH, Hoyt DB. Hypertonic saline enhances cellular immune function. Circ Shock 1994; 42: 190-6.
21. Junger WG, Hoyt DB, Davis RE et al. Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest 1998; 101: 2768-79.
22. Murao Y, Loomis W, Wolf P, Hoyt DB, Junger WG. Effect of dose of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock. Shock 2003; 20: 29-34.
23. Murao Y, Hoyt DB, Loomis W et al. Does the timing of hypertonic saline resuscitation affect its potential to prevent lung damage? Shock 2000; 14: 18-23.
24. Rizoli SB, Kapus A, Parodo J, Fan J, Rotstein OD. Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression. J Surg Res 1999; 83: 130-5.
25. Kramer GC, Perron PR, Lindsey DC et al. Small-volume resuscitation with hypertonic saline dextran solution. Surgery 1986; 100: 239-47.
26. Moon PF, Kramer GC. Hypertonic saline-dextran resuscitation from hemorrhagic shock induces transient mixed acidosis. Crit Care Med 1995; 23: 323-31.
27. Jarvela K, Kaukinen S. Hypertonic saline (7.5%) after coronary artery bypass grafting. Eur J Anaesthesiol 2001; 18: 100-7.
28. Tølløfsrud S, Tønnessen T, Skraastad Ø, Noddeland H. Hypertonic saline and dextran in normovolaemic and hypovolaemic healthy volunteers increases interstitial and intravascular fluid Volumes. Acta Anaesthesiol Scand 1998; 42: 145-53.
29. Mattox KL, Maningas PA, Moore EE et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Ann Surg 1991; 213: 482-91.
30. Younes RN, Aun F, Accioly CQ, Casale LP, Szajnbok I, Birolini D. Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery 1992; 111: 380-5.
31. Ciesla DJ, Moore EE, Gonzalez RJ, Biffl WL, Silliman CC. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. Shock 2000; 14: 265-9.
32. Ciesla DJ, Moore EE, Musters RJ, Biffl WL, Silliman CA. Hypertonic saline alteration of the PMN cytoskeleton: implications for signal transduction and the cytotoxic response. J Trauma 2001; 50: 206-12.
33. Orlic T, Loomis WH, Shreve A, Namiki S, Junger WG. Hypertonicity increases cAMP in PMN and blocks oxidative burst by PKA-dependent and - independent mechanisms. Am J Physiol Cell Physiol 2002; 282: C1261-9.
34. Rizoli SB, Rotstein OD, Parodo J, Phillips MJ, Kapus A. Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling. Am J Physiol Cell Physiol 2000; 279: C619-33.
35. Junger WG, Hoyt DB, Hamreus M et al. Hypertonic saline activates protein tyrosine kinases and mitogen-activated protein kinase p38 in T-cells. J Trauma 1997; 42: 437-43; discussion 443-5.
36. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A 1995; 92: 12230-4.
37. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol 2002; 168: 1389-96.
38. Bode JG, Peters-Regehr T, Schliess F, Haussinger D. Activation of mitogen-activated protein kinases and IL-6 release in response to lipopolysaccharides in Kupffer cells is modulated by anisoosmolarity. J Hepatol 1998; 28: 795-802.
39. Nahm O, Woo SK, Handler JS, Kwon HM. Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity. Am J Physiol Cell Physiol 2002; 282: C49-58.
40. Raingeaud J, Gupta S, Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270: 7420-6.
41. Rizoli SB, Kapus A, Parodo J, Rotstein OD. Hypertonicity prevents lipopolysaccharide-stimulated CD11b/CD18 expression in human neutrophils in vitro: role for p38 inhibition. J Trauma 1999; 46: 794-8; discussion 798-9.
42. Ciesla DJ, Moore EE, Biffl WL, Gonzalez RJ, Moore HB, Silliman CC. Hypertonic saline activation of p38 MAPK primes the PMN respiratory burst. Shock 2001; 16: 285-9.
43. Partrick DA, Moore EE, Offner PJ, Johnson JL, Tamura DY, Silliman CC. Hypertonic saline activates lipid-primed human neutrophils for enhanced elastase release. J Trauma 1998; 44: 592-7; discussion 598.
44. Ciesla DJ, Moore EE, Biffl WL, Gonzalez RJ, Silliman CC. Hypertonic saline attenuation of the neutrophil cytotoxic response is reversed upon restoration of normotonicity and reestablished by repeated hypertonic challenge. Surgery 2001; 129: 567-75.
45. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000; 343: 37-49.
46. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ. Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 1993; 80: 10-7.
47. Repo H, Harlan JM. Mechanisms and consequences of phagocyte adhesion to endothelium. Ann Med 1999; 31: 156-65.
48. Rivera-Chavez F, Toledo-Pereyra LH, Nora DT, Bachulis B, Ilgenfritz F, Dean RE. P-selectin blockade is beneficial after uncontrolled hemorrhagic shock. J Trauma 1998; 45: 440-5.
49. Fahrner SL, Shackford SR, Bourguignon P, Bednar M, Shatney-Leach L. Effect of medium tonicity and dextran on neutrophil function in vitro. J Trauma 2002; 52: 285-92.
50. Deitch EA, Shi HP, Feketeova E, Hauser CJ, Xu DZ. Hypertonic saline resuscitation limits neutrophil activation after trauma-hemorrhagic shock. Shock 2003; 19: 328-33.
51. Angle N, Hoyt DB, Cabello-Passini R, Herdon-Remelius C, Loomis W, Junger WG. Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma 1998; 45: 7-12; discussion 12-3.
52. Alam HB, Sun L, Ruff P, Austin B, Burris D, Rhee P. E- and P-Selectin Expression Depends on the Resuscitation Fluid Used in Hemorrhaged Rats. J Surg Res 2000; 94: 145-52.
53. Oreopoulos GD, Hamilton J, Rizoli SB et al. In vivo and in vitro modulation of intercellular adhesion molecule (ICAM) -1 expression by hypertonicity. Shock 2000; 14: 409-14.
54. Pascual JL, Khwaja KA, Ferri LE et al. Hypertonic saline resuscitation attenuates neutrophil lung sequestration and transmigration by diminishing leukocyte-endothelial interactions in a two-hit model of hemorrhagic shock and infection. J Trauma 2003; 54: 121-30.
55. Nolte D, Bayer M, Lehr HA et al. Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextran. Am J Physiol 1992; 263: H1411-6.
56. Saetzler RK, Buckman RF Jr, Eynon AC, Tuma RF. Hypertonic saline attenuates leukocyte/endothelium and leukocyte/platelet interactions following hemorrhagic shock. Surg Forum 1994; 47: 41-3.
57. Corso CO, Okamoto S, Rüttinger D, Messmer K. Hypertonic Saline Dextran Attenuates Leukocyte Accumulation in the Liver after Hemorrhagic Shock and Resuscitation. J Trauma 1999; 46: 417-33.
58. Bauer M, Marzi I, Ziegenfuss T, Seeck G, Bühren V, Larsen R. Comparative effects of crystalloid and small volume hypertonic hyperoncotic fluid resuscitation on hepatic microcirculation after hemorrhagic shock. Circ Shock 1993; 40: 187-93.
59. Vollmar B, Lang G, Menger MD, Messmer K. Hypertonic hydroxyethyl starch restores hepatic microvacular perfusion in hemorrhagic shock. Am J Physiol 1994; 266: H1927-34.
60. Spera PA, Arfors KE, Vasthare US, Tuma RF, Young WF. Effect of hypertonic saline on leukocyte activity after spinal cord injury. Spine 1998; 23: 2444-8; discussion 2448-9.
61. Härtl R, Medary MB, Ruge M, Arfos KE, Ghahremani F, Ghajar J. Hypertonic/hyperoncotic saline attenuates microcirculatory disturbances after traumatic brain injury. J Trauma 1997; 42: S41-7.
62. Angle N, Hoyt DB, Coimbra R et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock 1998; 9: 164-70.
63. Bryant RE, Sutcliffe MC, McGee ZA. Effect of osmolalities comparable to those of the renal medulla on function of human polymorphonuclear leukocytes. J Infect Dis 1972; 126: 1-10.
64. Akgur FM, Zibari GB, McDonald JC, Granger DN, Brown MF. Effects of dextran and pentoxifylline on hemorrhagic shock-induced P-selectin expression. J Surg Res 1999; 87: 232-8.
65. Steinbauer M, Harris AG, Messmer K. Effects of dextran on microvascular ischemia-reperfusion injury in striated muscle. Am J Physiol 1997; 272: H1710-6.
66. de Carvalho H, Matos JA, Bouskela E, Svensjo E. Vascular permeability increase and plasma Volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran. Shock 1999; 12: 75-80.
67. Shi HP, Deitch EA, Da Xu Z, Lu Q, Hauser CJ. Hypertonic saline improves intestinal mucosa barrier function and lung injury after trauma-hemorrhagic shock. Shock 2002; 17: 496-501.
68. Shields CJ, Winter DC, Sookhai S, Ryan L, Kirwan WO, Redmond HP. Hypertonic saline attenuates end-organ damage in an experimental model of acute pancreatitis. Br J Surg 2000; 87: 1336-40.
69. Shields CJ, Winter DC, Manning BJ, Wang JH, Kirwan WO, Redmond HP. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg 2003; 138: 9-14.
70. Coimbra R, Hoyt DB, Junger WG et al. Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma 1997; 42: 602-6; discussion 606-7.
71. Murao Y, Hata M, Ohnishi K et al. Hypertonic saline resuscitation reduces apoptosis and tissue damage of the small intestine in a mouse model of hemorrhagic shock. Shock 2003; 20: 23-8.
72. Sumas ME, Legos JJ, Nathan D, Lamperti AA, Tuma RF, Young WF. Tonicity of resuscitative fluids influences outcome after spinal cord injury. Neurosurgery 2001; 48: 167-72.
73. Ozguc H, Tokyay R, Kahveci N, Serdar Z, Gur ES. Hypertonic saline dextran alleviates hepatic injury in hypovolemic rats undergoing porta hepatis occlusion. Shock 2003; 19: 383-7.
74. Corso CO, Okamoto S, Leiderer R, Messmer K. Resuscitation with hypertonic saline dextran reduces endothelial cell swelling and improves hepatic microvascular perfusion and function after hemorrhagic shock. J Surg Res 1998; 80: 210-20.
75. Younes RN, Aun F, Ching CT et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock 1997; 7: 79-83.
76. Sun LL, Ruff P, Austin B et al. Early up-regulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in rats with hemorrhagic shock and resuscitation. Shock 1999; 11: 416-22.
77. Rhee P, Burris D, Kaufmann C et al. Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. J Trauma 1998; 44: 313-9.
78. Deb S, Martin B, Sun L et al. Resuscitation with lactated Ringer's solution in rats with hemorrhagic shock induces immediate apoptosis. J Trauma 1999; 46: 582-8.
79. Deb S, Sun L, Martin B et al. Lactated ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma 2000; 49: 47-53.
80. Rhee P, Wang D, Ruff P et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000; 28: 74-8.
81. Shields CJ, Sookhai S, Winter DC et al. Attenuation of pancreatitis-induced pulmonary injury by aerosolized hypertonic saline. Surg Infect (Larchmt) 2001; 2: 215-23.
82. Pascual JL, Khwaja KA, Chaudhury P, Christou NV. Hypertonic saline and the microcirculation. J Trauma 2003; 54: S133-40.
83. Parkin J, Cohen B. An overview of the immune system. Lancet 2001; 357: 1777-89.
84. de Fijter CW, Verbrugh HA, Peters ED et al. Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo. Adv Perit Dial 1991; 7: 150-3.
85. Warskulat U, Zhang F, Haussinger D. Modulation of phagocytosis by anisoosmolarity and betaine in rat liver macrophages (Kupffer cells) and RAW 264.7 mouse macrophages. FEBS Lett 1996; 391: 287-92.
86. McBride WT, Armstrong MA, McBride SJ. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia 1996; 51: 465-73.
87. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery 2000; 127: 117-26.
88. Shapiro L, Dinarello CA. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp Cell Res 1997; 231: 354-62.
89. Lang KS, Fillon S, Schneider D, Rammensee HG, Lang F. Stimulation of TNF alpha expression by hyperosmotic stress. Pflugers Arch 2002; 443: 798-803.
90. Oreopoulos GD, Bradwell S, Lu Z et al. Synergistic induction of IL-10 by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages. Surgery 2001; 130: 157-65.
91. Horton JW, Maass DL, White J, Sanders B. Hypertonic saline-dextran suppresses burn-related cytokine secretion by cardiomyocytes. Am J Physiol Heart Circ Physiol 2001; 280: H1591-601.
92. Coimbra R, Junger WG, Hoyt DB, Liu FC, Loomis WH, Evers MF. Hypertonic saline resuscitation restores hemorrhage-induced immunosuppression by decreasing prostaglandin E2 and interleukin-4 production. J Surg Res 1996; 64: 203-9.
93. Tonnesen E, Mickley H, Grunnet N. Natural killer cell activity during premedication, anaesthesia and surgery. Acta Anaesthesiol Scand 1983; 27: 238-41.
94. Blazar BA, Rodrick ML, O'Mahony JB et al. Suppression of natural killer-cell function in humans following thermal and traumatic injury. J Clin Immunol 1986; 6: 26-36.
95. Hirsh M, Dyugovskaya L, Bashenko Y, Krausz MM. Reduced rate of bacterial translocation and improved variables of natural killer cell and T-cell activity in rats surviving controlled hemorrhagic shock and treated with hypertonic saline. Crit Care Med 2002; 30: 861-7.
96. Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl J Med 2000; 343: 108-17.
97. Coimbra R, Junger WG, Liu FC, Loomis WH, Hoyt DB. Hypertonic/hyperoncotic fluids reverse prostaglandin E2 (PGE2) - induced T-cell suppression. Shock 1995; 4: 45-9.
98. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. implications for the anesthesiologist. Anesthesiology 2002; 97: 215-52.
99. Riedemann NC, Guo RF, Ward PA, Novel strategies for the treatment of sepsis. Nat Med 2003; 9: 517-24.
100. Hecke F, Schmidt U, Kola A, Bautsch W, Klos A, Kohl J. Circulating complement proteins in multiple trauma patients - correlation with injury severity, development of sepsis, and outcome. Crit Care Med 1997; 25: 2015-24.
101. Clark EC, Nath KA, Hostetter TH, Hostetter MK. Hyperosmolality impairs ammonia-mediated inflammation. implications for the renal medulla. Am J Physiol 1992; 263: R148-55.
102. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC. An assay for the mannan-binding lectin pathway of complement activation. J Immunol Meth 2001; 257: 107-16.
103. Summary JJ, Dubick MA, Zaucha GM, Kilani AF, Korte DW Jr., Wade CE. Acute and subacute toxicity of 7.5% hypertonic saline/6% dextran-70 (HSD) in dogs. 1. Serum immunoglobulin and complement responses. J Appl Toxicol 1992; 12: 261-6.
104. Powers KA, Woo J, Khadaroo RG, Papia G, Kapus A, Rotstein OD. Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages. Surgery 2003; 134: 312-8.
105. Gushchin V, Stegalkina S, Alam HB, Kirkpatrick JR, Rhee PM, Koustova E. Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids. J Trauma 2002; 52: 867-71.
106. Gushchin V, Alam HB, Rhee P, Kirkpatrick JR, Koustova E. cDNA profiling in leukocytes exposed to hypertonic resuscitation fluids. J Am Coll Surg 2003; 197: 426-32.